Latest Financial Management News

Altamin Limited has successfully closed the institutional tranche of its 45-for-100 entitlement offer, raising $3.43 million with full participation from its major shareholder, the Victor Smorgon Group. The retail offer opens on 29 September, presenting shareholders with a chance to invest at the same price.

Clover Corporation Limited has reported a robust financial year ending July 2025, with revenue climbing 38% and net profit soaring to $7 million. The company also announced a higher fully franked final dividend, reflecting its strengthened financial position.

Highfield Resources has negotiated a standstill agreement with key noteholders, delaying enforcement actions on matured convertible notes and buying vital time to secure funding for its flagship Muga Potash Project in Spain.

Polymetals Resources reports steady operational gains at its Endeavor silver-zinc mine, hitting key production and financial milestones including a scheduled first zinc concentrate shipment and inclusion in the ASX All Ordinaries Index.

Simble Solutions has exited its digital asset holdings, selling all Bittensor tokens at a slight loss following new ASX guidance. The company signals a strategic pivot away from digital assets in its treasury management.

Acrux Limited has received a $3.04 million R&D Tax Incentive rebate for FY25 and fully repaid its short-term funding facility, underscoring its commitment to Australian pharmaceutical innovation.

Gibb River Diamonds has officially started mining operations at its Edjudina Gold Project in Western Australia, leveraging a contract mining model that shields the company from upfront costs. The Neta Prospect's gold production will be processed through toll milling agreements, with profits shared equally between Gibb River and contractor BML Ventures.

Norwood Systems has extended its loan repayment deadline to early September 2025, maintaining favorable terms with Balmain Resources. This ongoing financial support has been pivotal in securing key contracts and driving growth.

Papyrus Australia has marked significant progress in July 2025 with successful testing at its Rapid Prototyping facility and advancing plans for a commercial production site, while also writing down key investments.

Immutep Limited reported a widened loss of A$61.4 million for FY2025, driven by increased R&D and clinical trial expenses, while progressing its lead immunotherapy candidate into a pivotal Phase III lung cancer trial. The company maintains a robust cash position supporting operations through 2026.

Harvey Norman Holdings reported a robust 39% jump in profit before tax for FY25, driven by strong franchise sales, a booming property portfolio, and strategic international expansion.

Boss Energy reports a strong financial foundation with positive operating cash flow and a robust balance sheet in FY2025, its first full year of uranium production. Despite a net loss driven by non-cash costs, the company positions itself for growth amid rising uranium prices.